Nuvation Bio, Inc. (NUVB)

NYSE: NUVB · IEX Real-Time Price · USD
2.51
+0.01 (0.40%)
Oct 6, 2022 10:29 AM EDT - Market open

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Net Income
-86.85-41.66-33.55
Depreciation & Amortization
0.370.10.01
Share-Based Compensation
9.272.20
Other Operating Activities
9.022.839.11
Operating Cash Flow
-68.19-36.53-24.43
Capital Expenditures
-0.28-0.15-0.66
Change in Investments
-454.39-70.18-115.2
Investing Cash Flow
-454.67-70.32-115.86
Share Issuance / Repurchase
625.53135.665.01
Debt Issued / Paid
0014.39
Other Financing Activities
0-2.52124.22
Financing Cash Flow
625.53133.14143.62
Net Cash Flow
102.6726.293.33
Free Cash Flow
-68.47-36.67-25.09
Free Cash Flow Per Share
-0.35-0.38-0.12
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).